<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Preoperative physiologic pulmonary evaluation for lung resection</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Preoperative physiologic pulmonary evaluation for lung resection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Preoperative physiologic pulmonary evaluation for lung resection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven E Weinberger, MD, MACP, FRCP</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Lung resection is frequently considered in patients with lung cancer, and less commonly, in patients with some benign disorders (eg, localized bronchiectasis). For patients with lung cancer, surgery (typically lobectomy or pneumonectomy) is the only cure and is associated with the best long term survival; thus, pushing the boundaries of resectability in the lung cancer population is critical.</p><p>In many cases surgical resection needs to be considered in patients with impaired pulmonary function who have risk factors for complications. The evaluation involves assessing the effect of resection on the postoperative level of lung function as well as on the development of cardiopulmonary complications. In this topic, we discuss the approach to assessing the effect of resection on postoperative lung function. Importantly, the recommendations outlined in this topic assume that the cardiovascular risk is low. General preoperative pulmonary and cardiovascular assessments are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a> and  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a>.)</p><p class="headingAnchor" id="H2053120512"><span class="h1">GUIDELINES</span><span class="headingEndMark"> — </span>Most recommendations for lung resection have been informed by the American College of Chest Physicians  (<a class="graphic graphic_algorithm graphicRef93550" href="/z/d/graphic/93550.html" rel="external">algorithm 1</a>) [<a href="#rid1">1</a>] and the European Respiratory Society/European Society of Thoracic Surgeons (please refer to Figure 2 in the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Ferj.ersjournals.com%2Fcontent%2F34%2F3%2F782.full.pdf%2Bhtml&amp;token=W55%2BGjK6XLRq7Ny4PChtbr1HCfauziKS3ihZn96SzWMcC0%2FsxfScqiLc5AxnsfuNKKWitMcOYdnr7%2BbnINKF%2B68AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=6973" target="_blank">guidelines</a>) [<a href="#rid2">2</a>]. Similarities and differences among these guidelines are described throughout the text of the individual sections in this topic. There is also an older set of guidelines available from the British Thoracic Society (2001) [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H1901782120"><span class="h1">INITIAL ASSESSMENT</span><span class="headingEndMark"> — </span>Initial preoperative evaluation for resective surgery in the office involves a general pulmonary assessment. Pulmonary function testing (PFTs), typically spirometry and diffusing capacity, should also be obtained in patients undergoing lung resection. PFTs are particularly important in those with underlying lung disease for estimating post-resective lung function (eg, chronic obstructive lung disease [COPD] and emphysema).</p><p class="headingAnchor" id="H1336185473"><span class="h2">General assessment including cardiovascular risk</span><span class="headingEndMark"> — </span>For patients who are being evaluated for pulmonary resective surgery (ie, lobectomy, pneumonectomy, wedge resection), a general history and examination should be performed. The clinician should assess the patient's understanding of the reason for resection and alternatives available. The clinician should also specifically look for a past history of resections (eg, surgery for old tuberculosis or bronchiectasis), COPD or emphysema, cystic lung disease, interstitial lung disease, or mixed components of lung diseases, all of which can affect tolerability of lung resection and post-resective lung function.</p><p>Patients should also be examined, looking for evidence of old thoracotomy or thoracoscopy scars and for signs of chronic hyperinflation (eg, increased resonance to percussion, accessory muscle use, pursed lip breathing, paradoxical retraction of the lower interspaces during inspiration [ie, Hoover's sign]) or severe restriction (eg, limited chest expansion).</p><p class="headingAnchor" id="H1357305257"><span class="h2">Chest computed tomography</span><span class="headingEndMark"> — </span>With the specific resective surgery in mind (ie, pneumonectomy versus lobectomy), imaging should be evaluated for the anatomy of the region of the lung to be resected, relationship of the disease to adjacent structures, and the possible presence of disease in lung tissue that will not be resected. Chest computed tomography (CT) best serves this purpose and is typically already available. The same chest CT can additionally be used to count segments for postoperative lung function prediction.</p><p>Patients undergoing resection are often at risk for other general, pulmonary, and cardiovascular complications, the evaluation for which is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a>.)</p><p class="headingAnchor" id="H2"><span class="h2">Preoperative pulmonary function</span><span class="headingEndMark"> — </span>We agree with guidelines that the forced expiratory volume in one second (FEV<sub>1</sub>; ie, spirometry) and the diffusing capacity for carbon monoxide (DLCO) should be measured in all patients in whom resectional surgery is being considered [<a href="#rid1">1-3</a>]. Although lung volumes are also classically measured, they do not factor in to predicting postoperative pulmonary function following resection. If testing has not been performed within the previous 6 to 12 months, new testing should be requested. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults"</a>.)</p><p class="headingAnchor" id="H3"><span class="h3">Spirometry and diffusing capacity</span><span class="headingEndMark"> — </span>The FEV<sub>1</sub> and DLCO have become the primary values used for preoperative assessment. Their main utility is to distinguish patients who are at low risk of surgery (both values are greater than or equal to 80 percent predicted) from those who may need further evaluation (one or more values are less than 80 percent predicted).</p><p class="bulletIndent1"><span class="glyph">●</span>Spirometry – The FEV<sub>1</sub> correlates well with the degree of respiratory impairment in patients with COPD, and it provides an indirect measure of pulmonary reserve. In studies evaluating a variety of preoperative spirometric values, a reduced preoperative FEV<sub>1</sub> (&lt;60 percent predicted) was the strongest predictor of postoperative complications [<a href="#rid4">4-9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diffusing capacity – Retrospective studies have reported that actual DLCO (as a percent of the predicted value) and predicted postoperative DLCO are the most important predictors of mortality and postoperative complications in patients undergoing resection [<a href="#rid10">10-12</a>]. (See <a class="local">'Predicted postoperative pulmonary function'</a> below.)</p><p></p><p class="headingAnchor" id="H3554803795"><span class="h3">Others</span><span class="headingEndMark"> — </span>Other measures such as indicators of gas exchange and other PFT parameters, although often performed, are not typically predictive of mortality or postoperative lung function and do not assist in determining optimal amounts of lung that can be resected.</p><p class="headingAnchor" id="H16891015"><span class="h4">Arterial blood gases</span><span class="headingEndMark"> — </span>Arterial blood gases have not proved to be as useful as measuring FEV<sub>1</sub> and DLCO. However, they may be indicated in the general assessment of patients undergoing surgery, which is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Arterial oxygen tension (PaO<sub>2</sub>) – There are no predictors or formulae that can estimate the chronic need for supplemental oxygen following resective surgery. In patients who are already receiving supplemental oxygen, removal of healthy gas exchanging surface area will likely increase the supplemental oxygen needs, and, as such, would preclude resective surgery. In contrast, the resting arterial<sub> </sub>PaO<sub>2</sub> may remain the same or improve when regions of the lung that are significantly diseased or obstructed undergo resection [<a href="#rid13">13,14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arterial carbon dioxide tension (PaCO<sub>2</sub>) – Hypercapnia (ie, PaCO<sub>2</sub> greater than 45 mmHg) has traditionally been considered a significant risk factor for pulmonary resection [<a href="#rid14">14</a>], although newer studies suggest no difference in the outcome [<a href="#rid15">15,16</a>]. However, hypercapnia may be a marker of poor underlying lung function. Thus, although hypercapnia, per se, is not a contraindication to surgery, surgery is frequently precluded in hypercapnic patients because of a low predicted postoperative FEV<sub>1</sub> or poor exercise performance.</p><p></p><p class="headingAnchor" id="H3677513587"><span class="h4">Maximum voluntary ventilation</span><span class="headingEndMark"> — </span>Maximal voluntary ventilation (MVV) represents an integrated test that takes into account both airflow and muscle strength. However, its strong dependence on patient effort has led to its removal from most standard pulmonary function testing, and it is now rarely used for preoperative evaluation.</p><p class="headingAnchor" id="H467556902"><span class="h1">SELECTING PATIENTS FOR FURTHER TESTING (ACCP APPROACH)</span><span class="headingEndMark"> — </span>We adhere to the American College of Chest Physicians (ACCP) algorithm when evaluating patients for resective surgery [<a href="#rid1">1</a>]. The approach outlined by the ACCP algorithm selects patients for further testing based upon the results of initial preoperative forced expiratory volume in one second (FEV<sub>1</sub>) and diffusing capacity for carbon monoxide (DLCO). It is important to recognize that these guidelines were written using data derived from the lung cancer population, which is the population in whom resective surgery is most commonly performed. Similar principles are used for patients undergoing resective surgery for benign disease. Importantly, the recommendations outlined in the sections below assume that the cardiovascular risk is low. (See <a class="local">'Preoperative FEV1 and DLCO ≥80 percent'</a> below and <a class="local">'Preoperative FEV1 and DLCO &lt;80 percent'</a> below.)</p><p>An alternative approach outlined by the European Respiratory Society/European Society of Thoracic Surgeons (ERS/ESTS) [<a href="#rid2">2</a>] is discussed below. (See <a class="local">'Alternate approach (ERS/ESTS)'</a> below.)</p><p>Despite clear guidelines by both societies, many clinicians do not adhere to them [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H1439406489"><span class="h2">Preoperative FEV1 and DLCO ≥80 percent</span><span class="headingEndMark"> — </span>Patients with a preoperative FEV<sub>1</sub> and DLCO that are both ≥80 percent predicted do not need to undergo further testing for assessing postoperative lung function or risk. These patients are considered low risk and can generally tolerate lobectomy or pneumonectomy without resulting in clinically significant residual lung dysfunction. (See <a class="local">'Low risk'</a> below.)</p><p>While in the past an FEV<sub>1 </sub>greater than two liters was considered low risk, this absolute cutoff is no longer widely used since it does not take into consideration size, or age [<a href="#rid3">3,18-20</a>].</p><p class="headingAnchor" id="H3696935487"><span class="h2">Preoperative FEV1 and DLCO &lt;80 percent</span><span class="headingEndMark"> — </span>Patients with a <strong>pre</strong>operative FEV<sub>1</sub> <strong>or</strong> DLCO &lt;80 percent predicted need to undergo further evaluation to allow calculation of predicted <strong>post</strong>operative (PPO) lung function [<a href="#rid1">1</a>]. While the ACCP supports PPO lung function assessment in this group [<a href="#rid1">1</a>], the ERS/ESTS suggest performing a cardiopulmonary exercise test (CPET), which is also appropriate and the details of which are below [<a href="#rid2">2</a>]. (See <a class="local">'Integrated cardiopulmonary exercise testing'</a> below and <a class="local">'Alternate approach (ERS/ESTS)'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h3">Predicted postoperative pulmonary function</span><span class="headingEndMark"> — </span>PPO values for FEV<sub>1</sub> and DLCO take into account the preoperative values, the amount of lung tissue to be resected (eg, one lung, one lobe, two lobes, partial lobe), and its contribution to overall lung function. The contribution of the region of lung that is to be resected to overall lung function can be determined by quantitative lung scintigraphy or by lung segment counting [<a href="#rid3">3,21-23</a>]; the latter is typically performed on chest computed tomography (CT; these tests are also termed "split lung function studies"). Although both methods can be used for calculating postoperative lung function, perfusion scintigraphy is the most widely used method in patients undergoing pneumonectomy while lung segment counting is recommended for patients undergoing lobectomy [<a href="#rid1">1-3</a>]. Lung segment counting is done on the chest CT performed for lung cancer staging. Scintigraphy plays a limited role in the assessment of patients undergoing lobectomy because of the difficulty in interpreting the contribution of individual lobes to the overall perfusion [<a href="#rid2">2</a>].</p><p>Several studies have shown that assessment using volumetric CT correlates better with postoperative lung function than segment counting or scintigraphy [<a href="#rid24">24</a>]. This method provides a 3-D quantification of the volume and relative volume percentages of each lung, and can stratify the results by lung thirds (upper, middle, and lower). Although volumetric CT analysis can also be performed on the routine preoperative chest CT, it is currently seldom used in clinical practice.</p><p>In the past, a predicted postpneumonectomy FEV<sub>1</sub> greater than 0.8 L was chosen as the threshold value for surgery [<a href="#rid25">25</a>]. However, we no longer use absolute cutoffs for FEV<sub>1</sub> or DLCO to predict risk of lung resection since functional status may vary depending upon age, gender, and height. Thus, estimates are expressed as percent predicted values rather than absolute numbers. Formulae for these PPO predictions are below.</p><p class="headingAnchor" id="H933865257"><span class="h4">Formula</span><span class="headingEndMark"> — </span>Quantitative lung scintigraphy or lung segment counting can be used to determine the PPO FEV<sub>1 </sub>and DLCO. Either method can be used but lung scintigraphy may be less accurate in patients undergoing lobectomy than pneumonectomy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quantitative lung scintigraphy: Perfusion method (pneumonectomy)</strong> – Although ventilation or perfusion scintigraphy can be used, perfusion methods are more widely used for calculating PPO lung function. We support guidelines from the ACCP that suggest quantitative radionuclide perfusion lung scanning to calculate the PPO FEV<sub>1</sub> in a patient undergoing pneumonectomy (<a class="calc calc_professional" href="/z/d/html/93498.html" rel="external">calculator 1</a>) [<a href="#rid1">1</a>]:</p><p></p><div class="formulaContainer"><div class="formula"><p>PPO FEV<sub>1</sub> = preoperative FEV<sub>1</sub> x (1 – fraction of total perfusion in the resected lung measured on radionuclide perfusion)</p></div></div><p class="bulletIndent1">The absolute value obtained is then compared with the predicted value for FEV<sub>1</sub> for that individual’s height, age, and gender to obtain the percent predicted postoperative FEV<sub>1</sub>. The same formula can be used to predict PPO DLCO by substituting values for diffusing capacity [<a href="#rid23">23,26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Segment counting: Anatomic method (lobectomy)</strong> – Lung segment counting on chest CT is used most commonly for predicting PPO lung function in patients undergoing lobectomy but can also be used for patients undergoing pneumonectomy. Using this method, the estimated postoperative FEV<sub>1</sub> is calculated by the formula (<a class="calc calc_professional" href="/z/d/html/93496.html" rel="external">calculator 2</a>) [<a href="#rid27">27</a>]:</p><p></p><div class="formulaContainer"><div class="formula"><p>PPO FEV<sub>1</sub> = preoperative FEV<sub>1</sub> x (1 – a/b) where "a" is the number of segments to be resected and "b" is the total number of unobstructed segments (total number of segments is 19 [typically 10 on the right and 9 on the left]).</p></div></div><p class="bulletIndent1">The value obtained is then compared with the predicted value for FEV<sub>1</sub> for that individual’s height, age, and gender to obtain the percent predicted postoperative FEV<sub>1</sub>.</p><p></p><p class="bulletIndent1">Analogous formulas can also be used for calculating PPO DLCO.</p><p></p><p class="headingAnchor" id="H2150156993"><span class="h4">Efficacy</span><span class="headingEndMark"> — </span>Data to support the use of these formulas are limited:</p><p class="bulletIndent1"><span class="glyph">●</span>Older data report good correlation between PPO lung function using scintigraphy and observed postoperative lung function (which was stable over time) following pneumonectomy [<a href="#rid28">28</a>]. However, following lobectomy, there was a disproportionate early loss in postoperative function (compared with the predicted loss), followed by significant functional improvement over time.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one study, a PPO FEV<sub>1</sub> that was 40 percent or more of the predicted normal value for that patient was associated with no postoperative mortality (in 47 patients), whereas a value less than 40 percent was associated with 50 percent mortality (in six patients) [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent study confirmed a correlation between PPO FEV<sub>1</sub> and the likelihood of postoperative complications in patients undergoing lung resection [<a href="#rid15">15</a>]. The odds ratio for complications was 1.46 for each 0.2 L decrease in PPO FEV<sub>1</sub>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In other studies, high morbidity and mortality were associated with a predicted PPO DLCO below 40 percent [<a href="#rid21">21,23</a>].</p><p></p><p class="headingAnchor" id="H3753676478"><span class="h3">Interpreting postoperative predictions</span><span class="headingEndMark"> — </span>We follow the ACCP algorithm that stratifies patients with a PPO FEV<sub>1</sub> and/or DLCO cutoff of 60 percent predicted to determine who needs additional evaluation in preparation for resective surgery [<a href="#rid1">1</a>]. An alternate approach issued by the ERS/ESTS is discussed below. (See <a class="local">'Alternate approach (ERS/ESTS)'</a> below.)</p><p class="headingAnchor" id="H3428824109"><span class="h4">Postoperative predicted FEV1 and DLCO ≥60 percent</span><span class="headingEndMark"> — </span>Based upon the low risk of death and cardiopulmonary complications when <strong>both</strong> the PPO FEV<sub>1</sub> and PPO DLCO are ≥60 percent, no further testing is necessary. These patients are considered low risk and the patient is deemed to have sufficient pulmonary function to undergo resectional surgery. (See <a class="local">'Low risk'</a> below.)</p><p class="headingAnchor" id="H335581234"><span class="h4">Postoperative predicted FEV1 or DLCO &lt;60 percent but ≥30 percent</span><span class="headingEndMark"> — </span>For patients with <strong>either</strong> PPO FEV<sub>1</sub> or PPO DLCO &lt;60 percent predicted, and where <strong>both values</strong> are ≥30 percent predicted, a low technology exercise test (either stair climb or a shuttle walk test) should be performed. There is likely a broad range of risk in this group. Low technology exercise testing is used to select those within this group that may proceed with resective surgery and those that need further testing, namely a CPET.</p><p class="headingAnchor" id="H2675446696"><span class="h5">Incremental shuttle walk test</span><span class="headingEndMark"> — </span>An incremental shuttle walk test (ISWT) distance greater than 400 meters (ie, 40 x 10 meter "shuttles") has been associated with a maximum oxygen uptake (VO<sub>2</sub>max) ≥15 mL/kg/minute [<a href="#rid1">1</a>]; these patients can undergo major thoracic surgery and do not need a CPET. In contrast, patients whose ISWT distance falls below this cutoff are at increased risk for perioperative mortality and cardiopulmonary complications; these patients should undergo CPET with measurement of VO<sub>2</sub>max [<a href="#rid1">1</a>]. (See <a class="local">'Integrated cardiopulmonary exercise testing'</a> below.)</p><p>Details of how this test is performed are provided separately. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults", section on 'Incremental shuttle walk test'</a>.)</p><p class="headingAnchor" id="H1391466733"><span class="h5">Stair climbing</span><span class="headingEndMark"> — </span>Patients whose exercise ability is equal to or above 22 meters on the stair climbing test are considered low risk and the patient is deemed to have sufficient pulmonary function to undergo resectional surgery (see <a class="local">'Low risk'</a> below). In contrast, patients whose exercise ability falls below the designated cutoff of 22 meters should undergo CPET for measurement of VO<sub>2</sub>max due to the increased risk for perioperative death and cardiopulmonary complications in this population [<a href="#rid1">1</a>]. (See <a class="local">'Integrated cardiopulmonary exercise testing'</a> below.)</p><p>Although poorly standardized, this form of testing has been shown to identify patients at increased risk for lung resection [<a href="#rid29">29-35</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective series of 640 lobectomy and pneumonectomy patients, attainment of a lower altitude (less than 12 meters) on a symptom-limited stair climbing test was associated with a twofold increase in the risk of cardiopulmonary complications and 13-fold increase in mortality, compared with climbing to a higher altitude (22 meters) [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective series of 160 patients studied one day prior to lung resection found that those who were able to climb more than eight flights of stairs, at their own pace, were less likely to experience complications than those who could climb fewer than seven flights of stairs (6.5 versus 50 percent) [<a href="#rid31">31</a>]. Patients who climbed between seven and eight flights of stairs had an intermediate risk of complications (30 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis of 13 articles, being unable to climb more than 10 meters in the stair climb test was associated with a 2.3-fold risk of complications [<a href="#rid35">35</a>].</p><p></p><p>Although this test is suggested in algorithms of patient selection for thoracic surgery, compliance with it may be poor due to a lack of standardization in pulmonary function laboratories and lack of reimbursement [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H2289228083"><span class="h4">Postoperative predicted FEV1 and DLCO &lt;30 percent</span><span class="headingEndMark"> — </span>If either PPO FEV<sub>1</sub> or PPO DLCO is &lt;30 percent, a formal CPET with measurement of VO<sub>2</sub>max should be performed.</p><p>Guidelines from the ACCP [<a href="#rid1">1</a>] and the ERS/ESTS [<a href="#rid2">2</a>] use a cutoff value for PPO FEV<sub>1</sub> or DLCO of 30 percent (rather than the 40 percent used in several studies), due to improvements in surgical technique and the belief that removal of hyperinflated, poorly functioning lung tissue during surgery ameliorates the calculated loss in lung function through a "lung volume reduction effect."</p><p class="headingAnchor" id="H3060188205"><span class="h5">Integrated cardiopulmonary exercise testing</span><span class="headingEndMark"> — </span>The most important measurement during CPET that correlates with postoperative complications is the maximum level of work achieved, as measured by the VO<sub>2</sub>max; other parameters measured during exercise provide little additional useful data, unless some undiscovered cardiovascular or other limitation to exercise is found incidentally [<a href="#rid36">36</a>]. All guideline groups agree on using cutoff values of 10 and 20 mL/kg/minute, where those who achieve a VO<sub>2</sub>max &gt;20 mL/kg/minute (or over 75 percent predicted) are considered low risk, and &lt;10 mL/kg/minute (or &lt;35 percent predicted) are high risk [<a href="#rid1">1</a>]. Patients who achieve a VO<sub>2</sub>max between 10 and 20 mL/kg/minute have a wide range of risk and are considered as "moderate risk" per the ACCP guidelines, which suggest individualizing the approach in this population. While the ERS/ESTS also agree on the wide range of risk in this group, they provide further guidance on how to select possible candidates for surgery; further details are provided below. (See <a class="local">'Determining the risk'</a> below and <a class="local">'Preoperative FEV1 and DLCO &lt;80 percent'</a> below.)</p><p>Studies supporting this approach are limited to observation studies [<a href="#rid21">21,22,37-44</a>]. Most physicians express VO<sub>2</sub>max in terms of mL/kg/minute, since it takes into account the patient's body mass and may increase the predictive power of the test [<a href="#rid21">21,38-40</a>]. As an example, one study found that only 1 of 10 patients able to achieve a VO<sub>2</sub>max greater than 20 mL/kg/minute had a postoperative complication, whereas all six patients with a VO<sub>2</sub>max below 15 mL/kg/minute experienced a postoperative complication [<a href="#rid38">38</a>]. As another example, 20 patients who were considered to be at high risk for resection by standard criteria, but who had a VO<sub>2</sub>max of 15 mL/kg/minute or greater, survived surgery and had an acceptable postoperative complication rate [<a href="#rid39">39</a>]. In contrast, several series have demonstrated that patients with VO<sub>2</sub>max &lt;10 mL/kg/minute are at very high risk for perioperative complications and mortality [<a href="#rid22">22,40,41</a>].</p><p>While it has become standard to express the VO<sub>2</sub>max in mL/kg/minute, it may also be used when expressed as a percentage of the predicted value. One report found that a VO<sub>2</sub>max &lt;43 percent of predicted was associated with a 90 percent probability of developing serious postoperative complications [<a href="#rid42">42</a>]. A cutoff value below 60 percent predicted was found to be prohibitive for resections involving more than one lobe, whereas a value above 75 percent predicted suggested a good outcome, regardless of the extent of resection. Two subsequent studies, including a total of 280 patients with potentially operable lung cancer, also noted increased mortality among those with VO<sub>2</sub>max &lt;50 percent of predicted [<a href="#rid43">43,44</a>].</p><p class="headingAnchor" id="H14"><span class="h1">ALTERNATE APPROACH (ERS/ESTS)</span><span class="headingEndMark"> — </span>The guidelines of the American College of Chest Physicians (ACCP)  (<a class="graphic graphic_algorithm graphicRef93550" href="/z/d/graphic/93550.html" rel="external">algorithm 1</a>) and those of the European Respiratory Society and the European Society of Thoracic Surgeons (ERS/ESTS) (see figure 2 in the guidelines at <a class="external" href="/external-redirect?target_url=http%3A%2F%2Ferj.ersjournals.com%2Fcontent%2F34%2F3%2F782.full.pdf%2Bhtml&amp;token=W55%2BGjK6XLRq7Ny4PChtbr1HCfauziKS3ihZn96SzWMcC0%2FsxfScqiLc5AxnsfuNKKWitMcOYdnr7%2BbnINKF%2B68AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=6973" target="_blank">http://erj.ersjournals.com/content/34/3/782.full.pdf+html</a>) differ slightly in the exact timing and indications for cardiopulmonary exercise testing (CPET) in the evaluation of a patient for potential lung resection [<a href="#rid1">1,2</a>]. The ERS/ESTS suggest performing CPET in all patients with a <strong>pre</strong>operative forced expiratory volume in one second (FEV<sub>1</sub>) or diffusing capacity for carbon monoxide (DLCO) &lt;80 percent predicted. In contrast, the ACCP uses predicted postoperative (PPO) values in this population to determine who should undergo CPET (see <a class="local">'Predicted postoperative pulmonary function'</a> above). However, for those who undergo CPET, they agree that patients with a maximal oxygen consumption (VO<sub>2</sub>max) &gt;20 mL/kg/minute are at low risk of death or developing complications following resective surgery while patients with a VO<sub>2</sub>max &lt;10 mL/kg/minute are considered high risk.</p><p class="headingAnchor" id="H3624488251"><span class="h2">Preoperative FEV1 and DLCO ≥80 percent</span><span class="headingEndMark"> — </span>Similar to the ACCP guidelines, in the ERS/ESTS algorithm, patients with a <strong>pre</strong>operative FEV<sub>1</sub> and DLCO ≥80 percent predicted are considered low risk and will likely tolerate resective surgery. (See <a class="local">'Low risk'</a> below.)</p><p class="headingAnchor" id="H2122030481"><span class="h2">Preoperative FEV1 and DLCO &lt;80 percent</span><span class="headingEndMark"> — </span>In contrast with the ACCP algorithm, in the ERS/ESTS algorithm, patients with a <strong>pre</strong>operative FEV<sub>1</sub> or DLCO &lt;80 percent predicted should undergo CPET-determined VO<sub>2</sub>max; VO<sub>2</sub>max then determines who undergoes PPO lung function testing (see <a class="local">'Integrated cardiopulmonary exercise testing'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a VO<sub>2</sub>max &gt;20 mL/kg/minute (or &gt;75 percent predicted) are considered low risk and are suitable for any type of lung resection (in agreement with the ACCP guidelines). (See <a class="local">'Determining the risk'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a VO<sub>2</sub>max &lt;10 mL/kg/minute (or &lt;35 percent predicted) are considered at high risk and noninvasive options are preferred (in agreement with the ACCP guidelines). (See <a class="local">'Determining the risk'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with a VO<sub>2</sub>max between 10 and 20 mL/kg/minute (or between 35 and 75 percent predicted) should undergo further testing to determine predicted <strong>post</strong>operative FEV<sub>1 </sub>and DLCO. The ACCP and ERS/ESTS guidelines agree that the risk of surgery varies significantly among patients with a VO<sub>2</sub>max between 10 and 20 mL/kg/minute; some may be suitable for surgery while some may not be well suited; the ERS/ESTS guidelines provide additional guidance for surgical candidacy within this category. (See <a class="local">'Predicted postoperative pulmonary function'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the PPO FEV<sub>1</sub> and PPO DLCO are both &gt;30 percent, then resection up to the calculated extent is allowed. (See <a class="local">'Moderate risk'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If at least one parameter (PPO FEV<sub>1</sub> and/or PPO DLCO) is &lt;30 percent, then a PPO peak VO<sub>2</sub>max is calculated. Patients with a PPO peak VO<sub>2</sub>max &lt;10 mL/kg/minute (or &lt;35 percent predicted) are considered high risk, and minimally invasive or noninvasive options should be sought (see <a class="local">'High risk'</a> below). In patients with a PPO peak VO<sub>2</sub>max ≥10 mL/kg/minute (or &gt;35 percent) predicted, resection is not absolutely contraindicated and resection up to the calculated extent is allowed. However, considerable judgment may be involved, and the patient must understand the higher risk, particularly when the PPO FEV<sub>1</sub> or DLCO is &lt;30 percent. (See <a class="local">'Moderate risk'</a> below.)</p><p></p><p class="bulletIndent2">The PPO<sub> </sub>VO<sub>2</sub>max is calculated using data derived from perfusion or other studies that predict postoperative lung function using the following formulas:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Perfusion scintigraphy for pneumonectomy (perfusion method): PPO peak VO<sub>2</sub>max  =  preoperative peak VO<sub>2</sub>max  x (1 - fraction of the total perfusion for the lung to be resected)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Segment counting for lobectomy (anatomic method): PPO peak VO<sub>2</sub>max  =  preoperative peak VO<sub>2</sub>max  x (1 - number of segments to be resected/total number of lung segments [typically 18]).</p><p></p><p class="headingAnchor" id="H417612235"><span class="h1">DETERMINING THE RISK</span><span class="headingEndMark"> — </span>Few studies provide strict definitions for risk associated with resective surgery, but the categories below are considered a reasonable guideline.</p><p class="headingAnchor" id="H2529671322"><span class="h2">Low risk</span><span class="headingEndMark"> — </span>In the low risk category, the expected risk of mortality is below 1 percent. Major anatomic resections can be safely performed in this group without incurring a significant risk of residual lung dysfunction. Patients who are typically included in this category are the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with preoperative forced expiratory volume in one second (FEV<sub>1</sub>) and diffusing capacity for carbon monoxide (DLCO) both being ≥80 percent predicted. (See <a class="local">'Preoperative FEV1 and DLCO ≥80 percent'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with predicted postoperative (PPO) FEV<sub>1</sub> and PPO DLCO that are both ≥60 percent. (See <a class="local">'Postoperative predicted FEV1 and DLCO ≥60 percent'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with PPO FEV<sub>1</sub> or PPO DLCO &lt;60 percent predicted but whose PPO FEV<sub>1</sub> and PPO DLCO are both ≥30 percent and who pass either a stair climb (ie, ≥22 meters) or a shuttle walk test (ie, ≥400 meters). (See <a class="local">'Postoperative predicted FEV1 or DLCO &lt;60 percent but ≥30 percent'</a> above.)</p><p></p><p class="headingAnchor" id="H612788753"><span class="h2">Moderate risk</span><span class="headingEndMark"> — </span>For patients in this category, morbidity and mortality of lung resection surgery and residual functional loss following resection may vary widely (eg, mortality may range from 2 to 9 percent). Recommendations for surgery are heavily influenced by the values of predicted postoperative testing, exercise tolerance, and extent of resection. Risks and benefits of the operation should be thoroughly discussed with the patient. (See <a class="local">'Postoperative predicted FEV1 and DLCO &lt;30 percent'</a> above and <a class="local">'Integrated cardiopulmonary exercise testing'</a> above.)</p><p>Patients included in this category are those with maximal oxygen consumption (VO<sub>2</sub>max) values between 10 and 20 mL/kg/minute. The European Respiratory Society/European Society of Thoracic Surgery (ERS/ESTS) guidelines suggest managing this group by calculating the PPO VO<sub>2</sub>max, the details of which are discussed above [<a href="#rid2">2</a>]. (See <a class="local">'Alternate approach (ERS/ESTS)'</a> above.)</p><p class="headingAnchor" id="H445891410"><span class="h2">High risk</span><span class="headingEndMark"> — </span>The risk of mortality in this group is generally higher than 10 percent. Considerable risk of severe cardiopulmonary morbidity and residual functional loss is expected. Patients should be counseled about alternative surgical (eg, minor resections or minimally invasive surgery) or nonsurgical options. (See <a class="local">'Integrated cardiopulmonary exercise testing'</a> above and  <a class="medical medical_review" href="/z/d/html/4636.html" rel="external">"Systemic therapy in resectable non-small cell lung cancer"</a> and  <a class="medical medical_review" href="/z/d/html/4617.html" rel="external">"Stereotactic body radiation therapy for lung tumors"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H1751079179"><span class="h2">Combined resection and lung volume reduction surgery</span><span class="headingEndMark"> — </span>Guidelines from the American College of Chest Physicians (ACCP) suggest that for patients undergoing resection for lung cancer, combining resective surgery with lung volume reduction surgery (LVRS) is appropriate [<a href="#rid1">1</a>]; this is predicated on the cancer being located in an area of upper lobe emphysema, and the patient's preoperative forced expiratory volume in one second (FEV<sub>1</sub>) and diffusing capacity for carbon monoxide (DLCO) both being &gt;20 percent predicted. Optimal patient selection criteria have not been precisely defined for this combined approach, and predicting postoperative lung function following combined LVRS and resective surgery is challenging since the FEV<sub>1 </sub>and DLCO are expected to improve following LVRS but worsen following resection. Further details on LVRS are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1430.html" rel="external">"Lung volume reduction surgery in COPD"</a>.)</p><p class="headingAnchor" id="H624815061"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110267.html" rel="external">"Society guideline links: Chronic obstructive pulmonary disease"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/112231.html" rel="external">"Society guideline links: Diagnosis and management of lung cancer"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Scope</strong> – The most common indication for lung resection is lung cancer, but resective surgery may also be indicated in patients with some benign lung disorders (eg, localized bronchiectasis). In many cases surgical resection needs to be considered in patients with impaired pulmonary function. Patients should be assessed to determine the effect of resection on the postoperative level of lung function as well as on the risk for development of cardiopulmonary complications. Guidelines from the American College of Chest Physicians (ACCP) are provided in the algorithm  (<a class="graphic graphic_algorithm graphicRef93550" href="/z/d/graphic/93550.html" rel="external">algorithm 1</a>). Guidelines from the European Respiratory Society (ERS)/European Society of Thoracic Surgery (ESTS) can be accessed in Figure 2 at the following site <a class="external" href="/external-redirect?target_url=http%3A%2F%2Ferj.ersjournals.com%2Fcontent%2F34%2F3%2F782.full.pdf%2Bhtml&amp;token=W55%2BGjK6XLRq7Ny4PChtbr1HCfauziKS3ihZn96SzWMcC0%2FsxfScqiLc5AxnsfuNKKWitMcOYdnr7%2BbnINKF%2B68AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=6973" target="_blank">http://erj.ersjournals.com/content/34/3/782.full.pdf+html</a>. (See <a class="local">'Introduction'</a> above and <a class="local">'Guidelines'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial assessment</strong> – Initial preoperative evaluation for resective surgery involves a general pulmonary assessment and pulmonary function tests (PFTs). Specifically, the forced expiratory volume in one second (FEV<sub>1</sub>) and diffusing capacity for carbon monoxide (DLCO) are the most useful PFT measurements that help predict tolerability of resection and the need for additional testing. (See <a class="local">'Initial assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>FEV</strong><strong><sub>1</sub></strong><strong> and DLCO ≥80 percent</strong> – Patients with a preoperative FEV<sub>1</sub> and DLCO that are both ≥80 percent predicted do not need to undergo further testing. These patients are considered low risk and can generally tolerate lobectomy or pneumonectomy without resulting in residual dysfunction. (See <a class="local">'Preoperative FEV1 and DLCO ≥80 percent'</a> above and <a class="local">'Low risk'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>FEV</strong><strong><sub>1</sub></strong><strong> and DLCO &lt;80 percent</strong> – Patients with a preoperative FEV<sub>1</sub> or DLCO &lt;80 percent predicted should have their predicted postoperative (PPO) FEV<sub>1</sub> and DLCO calculated. While the ACCP supports this approach, the ERS/ESTS suggest performing a cardiopulmonary exercise test (CPET) in this population, which is also appropriate. (See <a class="local">'Preoperative FEV1 and DLCO &lt;80 percent'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Calculating the PPO FEV</strong><strong><sub>1 </sub></strong><strong>and DLCO</strong> – The PPO FEV<sub>1 </sub>and DLCO should be calculated based upon the preoperative values and the fractional functional contribution of the lung to be resected (<a class="calc calc_professional" href="/z/d/html/93498.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/z/d/html/93496.html" rel="external">calculator 2</a>). The fractional contribution of the lung to be resected can be estimated with quantitative perfusion scanning or anatomic calculation of the number of segments to be resected. (See <a class="local">'Predicted postoperative pulmonary function'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PPO FEV<sub>1</sub> and PPO DLCO ≥60 percent – Patients with both PPO FEV<sub>1</sub> and PPO DLCO ≥60 percent predicted are considered low risk and should tolerate surgical lobectomy or pneumonectomy. (See <a class="local">'Interpreting postoperative predictions'</a> above and <a class="local">'Postoperative predicted FEV1 and DLCO ≥60 percent'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PPO FEV<sub>1</sub> or PPO DLCO &lt;60 percent – For patients with either PPO FEV<sub>1</sub> or PPO DLCO &lt;60 percent predicted, but both ≥30 percent predicted, a low technology exercise test (either stair climb or a shuttle walk test) should be performed. (See <a class="local">'Interpreting postoperative predictions'</a> above and <a class="local">'Postoperative predicted FEV1 or DLCO &lt;60 percent but ≥30 percent'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients who can climb ≥22 meters (on a stair climb test) or walk ≥400 meters (on a shuttle walk test) are considered low risk and should tolerate resective surgery. (See <a class="local">'Stair climbing'</a> above and <a class="local">'Incremental shuttle walk test'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients who fail to meet cutoffs for the stair climb (ie, &lt;22 meters) or shuttle walk test (ie, &lt;400 meters), a formal CPET is indicated with measurement of maximal oxygen consumption (VO<sub>2</sub>max).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>PPO FEV<sub>1</sub> or PPO DLCO &lt;30 percent – For patients with either the PPO FEV<sub>1</sub> or PPO DLCO &lt;30 percent, a CPET is indicated with measurement of VO<sub>2</sub>max. (See <a class="local">'Interpreting postoperative predictions'</a> above and <a class="local">'Postoperative predicted FEV1 and DLCO &lt;30 percent'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CPET</strong> – For patients who undergo CPET, we suggest the following (see <a class="local">'Integrated cardiopulmonary exercise testing'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>VO<sub>2</sub>max &gt;20 mL/kg/minute – Patients who can achieve a VO<sub>2</sub>max &gt;20 mL/kg/minute (or &gt;75 percent predicted) are likely to have an acceptable rate of postoperative complications and should tolerate resective surgery. (See <a class="local">'Low risk'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>VO<sub>2</sub>max &lt;10 mL/kg/minute – Patients with a VO<sub>2</sub>max &lt;10 mL/kg/minute (or less than 35 percent predicted) have an unacceptably high risk for the development of serious complications, including death, from resective lung surgery. These patients are best managed by minimally invasive or nonsurgical modalities. (See <a class="local">'High risk'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>VO<sub>2</sub>max between 10 and 20 mL/kg/minute – Patients that achieve a VO<sub>2</sub>max between 10 and 20 mL/kg/minute have a wide range of risk and are considered as "moderate risk" per the ACCP guidelines, which suggest individualizing the approach in this population. While the ERS/ESTS also agree on the wide range of risk in this group, they provide further guidance on how to select possible candidates for surgery. We agree with the ERS/ESTS approach that calculates the PPO VO<sub>2</sub>max in this population. If the PPO VO<sub>2</sub>max is &lt;10 mL/kg/minute (or &lt;35 percent), surgical candidacy is poor and minimal or nonresectional options should be sought. On the other hand, if the PPO VO<sub>2</sub>max is ≥10 mL/kg/minute (or ≥35 percent), resection up to the calculated extent is allowed; however, the patient must understand the higher risk, particularly if either the PPO FEV<sub>1</sub> or DLCO is &lt;30 percent predicted. (See <a class="local">'Moderate risk'</a> above and <a class="local">'Integrated cardiopulmonary exercise testing'</a> above and <a class="local">'Alternate approach (ERS/ESTS)'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143:e166S.</a></li><li><a class="nounderline abstract_t">Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34:17.</a></li><li><a class="nounderline abstract_t">British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89.</a></li><li><a class="nounderline abstract_t">Boushy SF, Billig DM, North LB, Helgason AH. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest 1971; 59:383.</a></li><li><a class="nounderline abstract_t">Colman NC, Schraufnagel DE, Rivington RN, Pardy RL. Exercise testing in evaluation of patients for lung resection. Am Rev Respir Dis 1982; 125:604.</a></li><li><a class="nounderline abstract_t">Keagy BA, Lores ME, Starek PJ, et al. Elective pulmonary lobectomy: factors associated with morbidity and operative mortality. Ann Thorac Surg 1985; 40:349.</a></li><li><a class="nounderline abstract_t">Boysen PG, Block AJ, Moulder PV. Relationship between preoperative pulmonary function tests and complications after thoracotomy. Surg Gynecol Obstet 1981; 152:813.</a></li><li><a class="nounderline abstract_t">Miller JI, Grossman GD, Hatcher CR. Pulmonary function test criteria for operability and pulmonary resection. Surg Gynecol Obstet 1981; 153:893.</a></li><li><a class="nounderline abstract_t">Olsen GN, Block AJ, Swenson EW, et al. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis 1975; 111:379.</a></li><li><a class="nounderline abstract_t">Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988; 96:894.</a></li><li><a class="nounderline abstract_t">Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 2008; 85:1158.</a></li><li><a class="nounderline abstract_t">Liptay MJ, Basu S, Hoaglin MC, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol 2009; 100:703.</a></li><li><a class="nounderline abstract_t">Tisi GM. Preoperative evaluation of pulmonary function. Validity, indications, and benefits. Am Rev Respir Dis 1979; 119:293.</a></li><li><a class="nounderline abstract_t">Dunn WF, Scanlon PD. Preoperative pulmonary function testing for patients with lung cancer. Mayo Clin Proc 1993; 68:371.</a></li><li><a class="nounderline abstract_t">Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest 1994; 105:753.</a></li><li><a class="nounderline abstract_t">Marshall MC, Olsen GN. The physiologic evaluation of the lung resection candidate. Clin Chest Med 1993; 14:305.</a></li><li><a class="nounderline abstract_t">Charloux A, Brunelli A, Bolliger CT, et al. Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Society (ERS). Interact Cardiovasc Thorac Surg 2009; 9:925.</a></li><li><a class="nounderline abstract_t">Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med 2012; 79 Electronic Suppl 1:eS17.</a></li><li><a class="nounderline abstract_t">Linden PA, Bueno R, Colson YL, et al. Lung resection in patients with preoperative FEV1 &lt; 35% predicted. Chest 2005; 127:1984.</a></li><li><a class="nounderline abstract_t">Win T, Jackson A, Sharples L, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J 2005; 25:594.</a></li><li><a class="nounderline abstract_t">Datta D, Lahiri B. Preoperative evaluation of patients undergoing lung resection surgery. Chest 2003; 123:2096.</a></li><li><a class="nounderline abstract_t">Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132:161S.</a></li><li><a class="nounderline abstract_t">Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139:902.</a></li><li><a class="nounderline abstract_t">Fernández-Rodríguez L, Torres I, Romera D, et al. Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography. J Thorac Cardiovasc Surg 2018; 156:2297.</a></li><li><a class="nounderline abstract_t">Miller JI Jr. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg 1993; 105:347.</a></li><li><a class="nounderline abstract_t">Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150:947.</a></li><li><a class="nounderline abstract_t">Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123:105S.</a></li><li><a class="nounderline abstract_t">Ali MK, Mountain CF, Ewer MS, et al. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest 1980; 77:337.</a></li><li><a class="nounderline abstract_t">Van Nostrand D, Kjelsberg MO, Humphrey EW. Preresectional evaluation of risk from pneumonectomy. Surg Gynecol Obstet 1968; 127:306.</a></li><li><a class="nounderline abstract_t">Olsen GN, Bolton JW, Weiman DS, Hornung CA. Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience. Chest 1991; 99:587.</a></li><li><a class="nounderline abstract_t">Brunelli A, Al Refai M, Monteverde M, et al. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest 2002; 121:1106.</a></li><li><a class="nounderline abstract_t">Brunelli A, Refai M, Xiumé F, et al. Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg 2008; 86:240.</a></li><li><a class="nounderline abstract_t">Brunelli A, Xiumé F, Refai M, et al. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration 2010; 80:207.</a></li><li><a class="nounderline abstract_t">Bernasconi M, Koegelenberg CF, von Groote-Bidlingmaier F, et al. Speed of ascent during stair climbing identifies operable lung resection candidates. Respiration 2012; 84:117.</a></li><li><a class="nounderline abstract_t">Boujibar F, Gillibert A, Gravier FE, et al. Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis. Thorax 2020; 75:791.</a></li><li><a class="nounderline abstract_t">Ribas J, Díaz O, Barberà JA, et al. Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J 1998; 12:1429.</a></li><li><a class="nounderline abstract_t">Eugene H, Brown SE, Light RW, et al. Maximum oxygen consumption: A physiologic guide to pulmonary resection. Surg Forum 1982; 33:260.</a></li><li><a class="nounderline abstract_t">Smith TP, Kinasewitz GT, Tucker WY, et al. Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis 1984; 129:730.</a></li><li><a class="nounderline abstract_t">Walsh GL, Morice RC, Putnam JB Jr, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg 1994; 58:704.</a></li><li><a class="nounderline abstract_t">Brunelli A, Belardinelli R, Refai M, et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 2009; 135:1260.</a></li><li><a class="nounderline abstract_t">Schuurmans MM, Diacon AH, Bolliger CT. Functional evaluation before lung resection. Clin Chest Med 2002; 23:159.</a></li><li><a class="nounderline abstract_t">Bolliger CT, Jordan P, Solèr M, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med 1995; 151:1472.</a></li><li><a class="nounderline abstract_t">Villani F, De Maria P, Busia A. Exercise testing as a predictor of surgical risk after pneumonectomy for bronchogenic carcinoma. Respir Med 2003; 97:1296.</a></li><li><a class="nounderline abstract_t">Win T, Jackson A, Sharples L, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest 2005; 127:1159.</a></li></ol></div><div id="topicVersionRevision">Topic 6973 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23649437" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19567600" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11209097" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5573198" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7081820" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Exercise testing in evaluation of patients for lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4051616" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Elective pulmonary lobectomy: factors associated with morbidity and operative mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7244959" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Relationship between preoperative pulmonary function tests and complications after thoracotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7302816" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pulmonary function test criteria for operability and pulmonary resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1124884" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pulmonary function evaluation of the lung resection candidate: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3193801" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diffusing capacity predicts morbidity and mortality after pulmonary resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18355489" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19798693" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/373529" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Preoperative evaluation of pulmonary function. Validity, indications, and benefits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8455398" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Preoperative pulmonary function testing for patients with lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8131537" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8519175" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The physiologic evaluation of the lung resection candidate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19752152" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Society (ERS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22614960" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Preoperative evaluation of the lung resection candidate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15951309" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lung resection in patients with preoperative FEV1&lt;35% predicted.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15802330" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Relationship between pulmonary function and lung cancer surgical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796194" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Preoperative evaluation of patients undergoing lung resection surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17873167" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2930068" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Preoperative assessment as a predictor of mortality and morbidity after lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30195604" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8429663" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Physiologic evaluation of pulmonary function in the candidate for lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7921468" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12527570" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The physiologic evaluation of patients with lung cancer being considered for resectional surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7357934" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5662851" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Preresectional evaluation of risk from pneumonectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1995212" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11948039" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Stair climbing test predicts cardiopulmonary complications after lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18573431" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110651" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Peak oxygen consumption measured during the stair-climbing test in lung resection candidates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572926" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Speed of ascent during stair climbing identifies operable lung resection candidates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32651199" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9877504" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Invasive exercise testing in the evaluation of patients at high-risk for lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Maximum oxygen consumption: A physiologic guide to pulmonary resection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6721272" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Exercise capacity as a predictor of post-thoracotomy morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7944692" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19029436" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11901909" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Functional evaluation before lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7735602" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Exercise capacity as a predictor of postoperative complications in lung resection candidates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14682410" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Exercise testing as a predictor of surgical risk after pneumonectomy for bronchogenic carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15821190" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cardiopulmonary exercise tests and lung cancer surgical outcome.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
